Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

    Abstract Full Text
    open access has multimedia
    JAMA Cardiol. 2024; 9(4):323-334. 10.1001/jamacardio.2023.5661

    This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.

  • Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial

    Abstract Full Text
    free access is active quiz
    JAMA. 2021; 326(1):46-55. 10.1001/jama.2021.8828

    This randomized clinical trial assesses the effect of a single intravenous infusion of bamlanivimab vs placebo on incidence of COVID-19 among residents and staff of skilled nursing and assisted living facilities.

  • Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2021; 4(6):e2114923. 10.1001/jamanetworkopen.2021.14923

    This cohort study examines the prevalence of coronary artery disease (CAD) among adults with well-controlled HIV and low to moderate risk of atherosclerotic cardiovascular disease using computed tomography angiography and assessment of inflammation and immune activation biomarkers.